The goal of this study is to collect biospecimens (blood and cystic fluid) and data from participants who have a pancreatic cyst that requires surgical resection. The blood and fluid samples will be analyzed for research into DNA, RNA, and proteins.
Voluntarily agree to participate by giving written informed consent prior to any study-specific procedures.
Subject at least 18 years of age and able to provide consent. Subject is willing and able to comply with requirements of the protocol.
Radiologically documented cyst of the pancreas for which surgical removal is clinically indicated.
Patient will be undergoing a surgical resection of their pancreatic cystic neoplasm.
Patient who is pregnant at the time of study enrollment and sample collection.
Patient will not be undergoing clinically indicated surgery for a pancreatic cystic neoplasm.
Patient is unwilling or unable to provide informed consent or comply with study procedures.
Participants will, primarily, be patients of the clinical Investigators at HOAG and Piedmont Healthcare hospitals who are or will be scheduled for surgical resection of their worrisome pancreatic cyst as part of their clinically indicated care.
Case-only
Prospective
Not listed
Characterize the miRNA and protein signatures in exosomes derived from blood and cyst fluids in patients with worrisome cystic pancreatic tumors
Click on the lead sponsor to view all of their trials.
Translational Genomics Research Institute
Lead sponsor
Hoag Memorial Hospital Presbyterian
Collaborator
City of Hope National Medical Center
Collaborator
Piedmont Healthcare
Collaborator
